AustralianSuper Pty Ltd

Position in LLY — ELI LILLY & Co

CIK 1694164 MELBOURNE, C3

Position in LLY

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$254,643,843

+$76,108,313 QoQ

Shares Held

276,856

+66.7% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

1.35%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AustralianSuper Pty Ltd holds $954,613,199 across 8 Drug Manufacturers - General names. LLY ranks #1 (26.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	276,856	$254,643,843
2	GILD	Gilead Sciences, Inc.	1,436,171	$200,159,152
3	PFE	Pfizer Inc	4,980,592	$139,855,023
4	BMY	Bristol Myers Squibb Co	2,125,356	$128,902,841
5	BIIB	Biogen Inc.	616,193	$112,966,662
6	MRK	Merck & Co., Inc.	575,397	$69,214,505
7	ABBV	AbbVie Inc.	204,149	$44,400,366
8	JNJ	Johnson & Johnson	18,290	$4,470,807

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$254,643,843	276,856	+66.7%	Shares	Sole	2026-05-07
2025-12-31	$178,535,530	166,129	+264.1%	Shares	Sole	2026-02-05
2025-09-30	$34,817,979	45,633	+132.7%	Shares	Sole	2025-11-12
2025-06-30	$15,288,921	19,613	+60.9%	Shares	Sole	2025-08-01
2025-03-31	$10,070,320	12,193	+310.8%	Shares	Sole	2025-05-05
2023-06-30	$1,391,932	2,968	-99.3%	Shares	Sole	2023-07-28
2021-09-30	$97,109,159	420,295	-15.4%	Shares	Sole	2021-11-12
2021-06-30	$113,990,189	496,646	+10.7%	Shares	Sole	2021-08-12
2021-03-31	$83,835,101	448,748	+205.2%	Shares	Sole	2021-05-14
2020-12-31	$24,827,584	147,048	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.